In particular, EGFR, MAPK3, and MAPK1 are involved in the HIF-1, estrogen, FoxO, and Rap1 signaling pathways as well as in central carbon metabolism in cancer, prostate cancer, focal adhesion, and gap junction pathways. Here, EGFR is linked to prostate carcinoma.